Hookipa Pharma (HOOK) Insider Trading & Ownership $1.95 +0.01 (+0.52%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Hookipa Pharma (NASDAQ:HOOK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.30%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$38,380.00Number OfInsiders Selling(Last 3 Years)0 Get HOOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Hookipa Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HOOK Insider Buying and Selling by Quarter Hookipa Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/21/2023Reinhard KanderaCFOBuy700$7.20$5,040.00 8/16/2023Reinhard KanderaCFOBuy800$7.10$5,680.00 7/11/2023Jorn AldagCEOBuy500$8.30$4,150.00 7/7/2023Jorn AldagCEOBuy500$8.10$4,050.00 7/5/2023Jorn AldagCEOBuy500$8.90$4,450.00 7/3/2023Jorn AldagCEOBuy500$8.90$4,450.00 6/30/2023Reinhard KanderaCFOBuy1,200$8.80$10,560.00 (Data available from 1/1/2013 forward) HOOK Insider Trading Activity - Frequently Asked Questions Who is on Hookipa Pharma's Insider Roster? The list of insiders at Hookipa Pharma includes Jorn Aldag, and Reinhard Kandera. Learn more on insiders at HOOK. What percentage of Hookipa Pharma stock is owned by insiders? 3.30% of Hookipa Pharma stock is owned by insiders. Learn more on HOOK's insider holdings. Which Hookipa Pharma insiders have been buying company stock? The following insiders have purchased HOOK shares in the last 24 months: Jorn Aldag ($17,100.00), and Reinhard Kandera ($21,280.00). How much insider buying is happening at Hookipa Pharma? Insiders have purchased a total of 4,700 HOOK shares in the last 24 months for a total of $38,380.00 bought. Hookipa Pharma Key ExecutivesMr. Joern Aldag (Age 60)Pres, CEO & Director Mr. Daniel Pinschewer (Age 44)Founder & Chief Scientific Officer Dr. Reinhard Kandera (Age 50)CFO & Director Mr. Anders Lilja Ph.D. (Age 46)Sr. VP of Technical Devel. Mrs. Nina WaibelCommunications & Investor Relations Mang. More Insider Trading Tools from MarketBeat Related Companies Pyxis Oncology Insider Buying ALX Oncology Insider Buying Regulus Therapeutics Insider Buying Karyopharm Therapeutics Insider Buying Skye Bioscience Insider Buying Genelux Insider Buying Cue Biopharma Insider Buying Vistagen Therapeutics Insider Buying Janone Insider Buying Applied Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:HOOK) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hookipa Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hookipa Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
